Literature DB >> 10744686

Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase.

M M Ouellette1, M Liao, B S Herbert, M Johnson, S E Holt, H S Liss, J W Shay, W E Wright.   

Abstract

Human fibroblasts expressing the catalytic component of human telomerase (hTERT) have been followed for 250-400 population doublings. As expected, telomerase activity declined in long term culture of stable transfectants. Surprisingly, however, clones with average telomere lengths several kilobases shorter than those of senescent parental cells continued to proliferate. Although the longest telomeres shortened, the size of the shortest telomeres was maintained. Cells with subsenescent telomere lengths proliferated for an additional 20 doublings after inhibiting telomerase activity with a dominant-negative hTERT mutant. These results indicate that, under conditions of limiting telomerase activity, cis-acting signals may recruit telomerase to act on the shortest telomeres, argue against the hypothesis that the mortality stage 1 mechanism of cellular senescence is regulated by telomere positional effects (in which subtelomeric loci silenced by long telomeres are expressed when telomeres become short), and suggest that catalytically active telomerase is not required to provide a protein-capping role at the end of very short telomeres.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744686     DOI: 10.1074/jbc.275.14.10072

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert.

Authors:  Yie Liu; Hue Kha; Mark Ungrin; Murray O Robinson; Lea Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.

Authors:  L P Ford; J W Shay; W E Wright
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

4.  Effects of double-strand break repair proteins on vertebrate telomere structure.

Authors:  Chao Wei; Rose Skopp; Minoru Takata; Shunichi Takeda; Carolyn M Price
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

5.  Does a sentinel or a subset of short telomeres determine replicative senescence?

Authors:  Ying Zou; Agnel Sfeir; Sergei M Gryaznov; Jerry W Shay; Woodring E Wright
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

6.  Modification of subtelomeric DNA.

Authors:  Susanne Steinert; Jerry W Shay; Woodring E Wright
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Cell cycle-regulated trafficking of human telomerase to telomeres.

Authors:  Rebecca L Tomlinson; Tania D Ziegler; Teerawit Supakorndej; Rebecca M Terns; Michael P Terns
Journal:  Mol Biol Cell       Date:  2005-12-07       Impact factor: 4.138

8.  Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres.

Authors:  Beáta E Jády; Patricia Richard; Edouard Bertrand; Tamás Kiss
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

9.  C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.

Authors:  Soma S R Banik; Chuanhai Guo; Allyson C Smith; Seth S Margolis; D Ashley Richardson; Carlos A Tirado; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.

Authors:  Shu Wu; Yuanlong Ge; Laiqiang Huang; Haiying Liu; Yong Xue; Yong Zhao
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.